• Policy
• Reyvow, a migraine drug aimed at clinicians
• by Lee, Tak-Sun Aug 11, 2022 06:03am

• Policy
• "May bring 60M courses of Omicron-adapted COVID-19 vaccines"
• by Lee, Jeong-Hwan Aug 11, 2022 06:03am

• Company
• AKLIEF can be prescribed at general hospitals
• by Eo, Yun-Ho Aug 10, 2022 05:53am

• Policy
• Will approval of brain function enhancers be revoked?
• by Lee, Hye-Kyung Aug 10, 2022 05:53am

• Company
• Gov improvement plan may reduce patient drug access
• by Eo, Yun-Ho Aug 10, 2022 05:53am

• Policy
• AZ seeks reimb of its triple inhaled therapy for COPD
• by Lee, Tak-Sun Aug 10, 2022 05:52am

• Policy
• When replacing Spinraza→Zolgensma, it should be injected
• by Lee, Hye-Kyung Aug 10, 2022 05:52am

• Policy
• Administration of Evusheld begins to prevent COVID-19
• by Kim, Jung-Ju Aug 9, 2022 05:57am

• Policy
• Oxiracetam’s next...ordeal of brain function enhancers
• by Lee, Tak-Sun Aug 9, 2022 05:56am

• Opinion
• [Reporter's view] COVID-19 vaccination strategy
• by Aug 9, 2022 05:56am